The Report Guru

According to the new market research report Optical Imaging Market is expected to reach USD 1,749.2 million by 2020. The market was valued at USD 989.0 million in 2015 and is expected to grow from 2015 to 2020. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=894 In this report, the global optical imaging market is segmented by techniques, products, applications, end users, geographic regions, and countries. It also discusses the key market drivers, restraints, opportunities, trends, and challenges of this market and its sub-markets. In 2013, North America accounted for the largest share of the global optical imaging market, followed by Europe and Asia-Pacific. Greater uptake of optical imaging products and the presence of large number of optical imaging products manufacturers in the North American and European region has led to their large market share in the optical imaging market. However, the Asia-Pacific region represents the substant

The prominent players in the dental equipment market are 3M Company (U.S.), A-dec Inc. (U.S.), BIOLASE Technology (U.S.), Carestream Health (U.S.), Danaher Corporation (U.S.), Dentsply International (U.S.), Ivoclar Vivadent (Liechtenstein), Midmark Corporation (U.S.), Planmeca Oy (Finland), and Sirona Dental Systems Inc. (U.S.). Danaher Corporation (U.S.) was the global leader in the dental equipment market in 2013. It is a well-known company and has an exhaustive product portfolio. The company adopted acquisitions as its key business strategy to uphold its leadership position in the dental equipment market. In this regard, in June 2014, Kerr Corporation (a subsidiary of Danaher Corporation) acquired DUX Dental (U.S.) and Vettec Inc. (U.S.), two dental imaging companies. According to research report dental equipment’s market is projected to reach USD 7.5 billion by 2021 from USD 5.9 billion in 2016, at a CAGR of 4.9%. Get More Details - Download PDF Brochure :  https

Factors such as the growing need to manage regulatory compliance through the use of eHealth solutions, the need to curtail escalating healthcare costs, increasing government initiatives supporting the use of eHealth solutions and services, the high prevalence of chronic diseases, shift towards patient-centric healthcare delivery, and rising usage of big data are majorly driving the growth of this market. According to the new market research report eHealth Market is expected to reach USD 132.35 Billion by 2023 from USD 47.60 Billion in 2018, at a CAGR of 22.7%. The Asia Pacific region is expected to register the highest growth rate in the global eHealth market during the forecast period. Growing medical tourism, growing consumerism in the healthcare industry, accelerated economic growth of countries in the region, the implementation of new ICT guidelines, and the implementation of eHealth programs are the factors propelling the growth of the market in this region. Downloa

The gel documentation systems market size is expected to reach USD 304 million by 2023 from USD 258 million in 2018, at a CAGR of 3.3 %. The major factors driving the market are growing global incidence of infectious diseases and genetic disorders and increase in funding for research & development in genomics, proteomics, and electrophoresis techniques. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17162887 On the basis of product type, the gel documentation systems market is categorized into instruments, software, and accessories The instruments segment is further categorized into film gel documentation instruments and digital gel documentation instruments. It is expected to register a highest growth rate during the forecast period. The growth is attributed to high usage of gel documentation systems in molecular biology techniques in pathology laboratories and research & development institutions. On the basis of light source, t

Factors such as increasing prevalence of cardiovascular diseases across major markets, procedural benefits offered by mechanical thrombectomy in cardiac surgeries, higher prevalence of thrombotic diseases among geriatric individuals, and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries. According to research report the global thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222966801 In this report, the market has been segmented by type, application, end user, and region. In 2016, North America held the largest share of the market • Based on application, the market is segmented into cardiovascular, neurovascular, and peripheral vascular applications. Peripheral vascular segment is expected to be the fastest growing in the market during the forecast period. This growth ca

According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period. Growth in clinical microbiology market can be attributed to factors such as rising incidence of infectious diseases and growing outbreak of epidemics and increased funding and public-private investments. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367 The global clinical microbiology market is segmented by product, disease area, end user, and region. On the basis of products, the clinical microbiology market is segmented into instruments, and reagents. The reagents product segment is expected to grow at the fastest rate during the forecast period. The high growth of reagents segment is attributed to the high prevalence of infectious diseases across major markets (resulting in a growing number of clinical diagnostic procedures), growing trend of r

Market growth is largely driven by the rising global disease prevalence, life expectancy, and geriatric population. Technological advancements have prompted end users to overhaul or update their manufacturing systems. As this is a costly process, they look to contract manufacturing. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851 According to research report the Medical Device Contract Manufacturing Market is expected to reach USD 91.3 billion by 2024 from an estimated USD 55.0 billion in 2019, at a CAGR of 10.6%. Jabil Inc. (US) was the leader in the medical device contract manufacturing market in 2018. The company offers a focused range of products such as diagnostic devices, diabetes care devices, ophthalmology devices, pharmaceutical drug delivery devices, and consumables for medical devices and services such as additive manufacturing, contract manufacturing, quality management services, and final goods assembly services. It al

The high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favourable reimbursement scenario for sinus procedures in developed countries are the major factors driving the growth of the market. According to research report the sinus dilation devices market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 The high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries are the major factors driving the growth of the market. However, the dearth of skilled otolaryngologists and ENT surgeons is expected to challenge market growth

According to research report the global In Vitro Diagnostics Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. The market for IVD quality control is primarily driven by increasing demands for laboratory accreditation, as well as the rising number of accredited laboratories and growing adoption of third-party quality controls. However, the lack of regulations for clinical laboratory accreditation in several emerging countries will challenge market growth. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Based on product and service, the IVD quality control market is segmented into quality control products, data management solutions, and quality assurance services. In 2019, quality control products accounted for the largest share of the global IVD quality control market. Growth in the quality control products market can be attributed to the

According to the new market research report Immunoassay Market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The increasing incidence of chronic and infectious diseases, technological advancements in immunoassay instruments and introduction of novel automated systems, and growth in the biotechnology and biopharmaceutical industries are some the major factors driving the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Restraints: Unfavourable reimbursement scenario Inadequate reimbursement is a major factor restraining the growth of the immunoassay market. In the US, Medicare revised its reimbursement mechanism for some IVD tests, including immunoassays and molecular tests, in 2012. Some of these molecular pathology tests do not have their own Healthcare Common Procedure Coding System (HCPCS) codes and are instead billed using unlisted codes. In such cases, Me